Live Breaking News & Updates on Specialty Pharma

Stay updated with breaking news from Specialty pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Medios : Unternehmenspräsentation - MarketScreener

Medios : Unternehmenspräsentation - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Company Presentation , Frankfurt Stock Exchange Prime Standard , Specialty Pharmaceuticals , European Specialty Pharma Platform , Specialty Pharma , Investment Highlights , Frankfurt Stock Exchange , Prime Standard ,

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance

EQS-News: Medios AG

/ Key word: Quarterly / Interim Statement/Quarter Results

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year. ....

Claudia Nickolaus , Matthias Gaertner , Goldman Sachs , Medios Group , Ceban Pharmaceuticalsbv , Specialty Pharma Solutions , Ceban Pharmaceuticals , Specialty Pharma , Pharmaceutical Supply , Patient Specific Therapies , Blister Gmbh , Chief Executive Officer , European Specialty Pharma , Specific Therapies , Warburg Highlights , Half Year Financial Report , Annual General Meeting , Investor Relations , Regulated Market , Frankfurt Stock Exchange , Prime Standard , Public Relations ,

TELES Informationstechnologien : Annual Financial Statements 2023

Translation - the German version is authoritative

Annual Report

and

. ....

Arzneimittel Gmb , Rechenzentrum Gmb , Marktprognose Apotheken , Health Gmb , Carrier Solutions , Group Management Board , International Financial Reporting Standards , International Monetary Fund , Research Development , German Commercial Code , Supervisory Board , German Accounting Standard , Specialty Pharma , Unified Communication , German Clinic , Reproductive Medicine Gmbh , Carrier Solution ,

60 Degrees Pharmaceuticals to Sponsor Pilot Study of

60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease.. ....

United States , Patrick Gaynes , Sheilaa Burke , United States Army , Exchange Commission , Materiel Development Activity , Degrees Pharmaceuticals Inc , Drug Administration , Degrees Pharmaceuticals , Company Type , Walter Reed Army Institute Of Research , Carolina State University , North Carolina State University , Canine Babesiosis Pilot , Institutional Animal Care , Use Committee , Walter Reed Army Institute , Materiel Development , Institutional Review Board , Investigational New Drug Application , Investigational New Drug , Securities Litigation Reform Act , Registration Statement , Nasdaq Sxtp , Sixty Degrees Pharmaceuticals , 60 Degrees Pharmaceuticals ,

Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO

～Hidemasa s appointment bolsters Aculys position as a leader in the field of CNS in Japan and Asia～ ....

Minato Ku , United States , Takeshi Takahashi , Aculys Pharma , Hidemasa Tanigaki , Nihon Pharmaceutical Co Ltd , Takeda Pharmaceutical Company , Prnewswire Aculys Pharma Inc , Aculys Pharma Inc , Chief Executive Officer , Representative Director , Sales Director , Specialty Pharma , Rare Hematology , Gastrointestinal Disease Business Unit , Executive Chairperson , Aculys Board ,